drugset / Trial / NCT03669757
Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis
RandomizedParallel-groupSingle-blindTreatment
Summary
To assess safety and tolerability after treatment with LEO 134310 cutaneous solution.
Timeline
- Start
- 2018-09-27
- Primary completion
- 2019-02-01
- Completion
- 2019-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LEO 134310 | Unknown | — | Topical |
| Comparator | betamethasone valerate | Small molecule | 0.1 % | Topical |